Pacira BioSciences (PCRX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Pacira BioSciences (PCRX) over the last 17 years, with Q3 2025 value amounting to $221.5 million.
- Pacira BioSciences' Other Gross PP&E Adjustments fell 304.75% to $221.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.5 million, marking a year-over-year decrease of 304.75%. This contributed to the annual value of $250.9 million for FY2024, which is 107.29% up from last year.
- According to the latest figures from Q3 2025, Pacira BioSciences' Other Gross PP&E Adjustments is $221.5 million, which was down 304.75% from $232.8 million recorded in Q2 2025.
- Over the past 5 years, Pacira BioSciences' Other Gross PP&E Adjustments peaked at $250.9 million during Q4 2024, and registered a low of $147.3 million during Q1 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $211.2 million (2022), whereas its average is $205.4 million.
- In the last 5 years, Pacira BioSciences' Other Gross PP&E Adjustments surged by 5724.71% in 2021 and then plummeted by 304.75% in 2025.
- Over the past 5 years, Pacira BioSciences' Other Gross PP&E Adjustments (Quarter) stood at $197.2 million in 2021, then increased by 16.67% to $230.1 million in 2022, then increased by 7.86% to $248.2 million in 2023, then increased by 1.07% to $250.9 million in 2024, then decreased by 11.71% to $221.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at $221.5 million for Q3 2025, versus $232.8 million for Q2 2025 and $212.5 million for Q1 2025.